Javascript must be enabled to continue!
Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy
View through CrossRef
Summary
Purpose:
Vigabatrin used to treat infantile spasms (IS) has been associated with transient magnetic resonance imaging (MRI) abnormalities. We carried out a retrospective review to better characterize the frequency of those abnormalities in IS and in children and adults treated with vigabatrin for refractory complex partial seizures (CPS).
Methods:
Medical records and 332 cranial MRIs from 205 infants (aged ≤24 months) with IS treated at 10 sites in the United States and Canada were collected. Similarly, 2,074 images from 668 children (aged 2–16 years) and adults (aged >16 years) with CPS were re‐reviewed. Prespecified MRI abnormalities were defined as any hyperintensity on T
2
‐weighted or fluid‐attenuated inversion‐recovery (FLAIR) sequences with or without diffusion restriction not readily explained by a radiographically well‐characterized pathology. MRIs were read by two neuroradiologists blinded to treatment group. The incidence and prevalence of MRI abnormalities associated with vigabatrin were estimated.
Results:
Among infants with IS, the prevalence of prespecified MRI abnormalities was significantly higher among vigabatrin‐treated versus vigabatrin‐naive subjects (22% vs. 4%; p
<
0.001). Of nine subjects in the prevalence population with at least one subsequent determinate MRI, resolution of MRI abnormalities occurred in six (66.7%)—vigabatrin was discontinued in four. Among adults and children treated with vigabatrin for CPS, there was no statistically significant difference in the incidence or prevalence of prespecified MRI abnormalities between vigabatrin‐exposed and vigabatrin‐naive subjects.
Discussion:
Vigabatrin is associated with transient, asymptomatic MRI abnormalities in infants treated for IS. The majority of these MRI abnormalities resolved, even in subjects who remained on vigabatrin therapy.
Title: Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy
Description:
Summary
Purpose:
Vigabatrin used to treat infantile spasms (IS) has been associated with transient magnetic resonance imaging (MRI) abnormalities.
We carried out a retrospective review to better characterize the frequency of those abnormalities in IS and in children and adults treated with vigabatrin for refractory complex partial seizures (CPS).
Methods:
Medical records and 332 cranial MRIs from 205 infants (aged ≤24 months) with IS treated at 10 sites in the United States and Canada were collected.
Similarly, 2,074 images from 668 children (aged 2–16 years) and adults (aged >16 years) with CPS were re‐reviewed.
Prespecified MRI abnormalities were defined as any hyperintensity on T
2
‐weighted or fluid‐attenuated inversion‐recovery (FLAIR) sequences with or without diffusion restriction not readily explained by a radiographically well‐characterized pathology.
MRIs were read by two neuroradiologists blinded to treatment group.
The incidence and prevalence of MRI abnormalities associated with vigabatrin were estimated.
Results:
Among infants with IS, the prevalence of prespecified MRI abnormalities was significantly higher among vigabatrin‐treated versus vigabatrin‐naive subjects (22% vs.
4%; p
<
0.
001).
Of nine subjects in the prevalence population with at least one subsequent determinate MRI, resolution of MRI abnormalities occurred in six (66.
7%)—vigabatrin was discontinued in four.
Among adults and children treated with vigabatrin for CPS, there was no statistically significant difference in the incidence or prevalence of prespecified MRI abnormalities between vigabatrin‐exposed and vigabatrin‐naive subjects.
Discussion:
Vigabatrin is associated with transient, asymptomatic MRI abnormalities in infants treated for IS.
The majority of these MRI abnormalities resolved, even in subjects who remained on vigabatrin therapy.
Related Results
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
1
Jose F.
Tellez‐Zenteno,
1
Scott B.
Patten, and
1
Samuel
Wiebe
...
Portrait of Epilepsy on the Canvas of Global Health
Portrait of Epilepsy on the Canvas of Global Health
Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD Epilepsy Collabora...
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase
Aims Decreases in plasma alanine transaminase (ALA‐T) activity of 20–100% have been reported following the use of vigabatrin (Sabril) in patients with uncontrolled epilepsy. This e...
Infantile Spasms and Epilepsy Currents
Infantile Spasms and Epilepsy Currents
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial Lux AL, Edwards SW, Hanco...
Neuropathology in the North American sudden unexpected death in epilepsy registry
Neuropathology in the North American sudden unexpected death in epilepsy registry
Abstract
Sudden unexpected death in epilepsy is the leading category of epilepsy-related death and the underlying mechanisms are incompletely understood. Risk factor...
Prevalence of epilepsy and the epilepsy treatment gap in Bauchi, Northeast Nigeria: a cross-sectional study of two communities
Prevalence of epilepsy and the epilepsy treatment gap in Bauchi, Northeast Nigeria: a cross-sectional study of two communities
Objective
Epilepsy prevalence varies widely across Nigeria, with rates ranging from 3.1 to 37.0/1000 population. There have been no studies on epilepsy prevalen...
Level of awareness, knowledge, and attitudes toward epilepsy among students at king Khalid university, Saudi Arabia
Level of awareness, knowledge, and attitudes toward epilepsy among students at king Khalid university, Saudi Arabia
purpose: Epilepsy is a major public health problem worldwide. The aim of this study was to explore the level of awareness, knowledge regarding epilepsy and attitudes prevalent towa...
Pharmacology of Vigabatrin
Pharmacology of Vigabatrin
Abstract: Vigabatrin (gamma‐vinyl GABA) is a relatively new antiepileptic drug. Vigabatrin increases the concentration of gamma‐aminobutyric acid (GABA) in the brain by inhibiting...

